F-18-FDG Positron imaging in oncological patients: Gamma camera coincidence detection versus dedicated PET

NuklearMedizin

Volumn 38, Issue 4, 1999, Pages 108-114

  Zimny, Michael ^a   Kaiser, H J ^b   Cremerius, U ^b   Sabri, O ^b   Schreckenberger, M ^b   Reinartz, P ^b   Bull U ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Coincidence gamma camera; Fluorine 18 fluorodeoxyglucose; Lesion detection; Oncology; Positron emission tomography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA;

EID: 0033054415     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1632201     Document Type: Article

References (32)

1. Abdel-Dayem HM, Radin AI, Luo JO et al. Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma. J Nucl Med 1998; 39: 654-6.
2. Bares R, Klever P, Hauptmann S et al. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192: 79-86.
3. Bengel FM, Ziegler SI, Avril N et al. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrecled images. Eur J Nucl Med 1997; 24: 1091-8.
4. Burt RW, Perkins OW, Oppenheim BE. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995; 36: 176-9.
5. Cochavi S, Goldsmith SJ, Strashun A et al. Planar imaging of positron emitting radionuclides with multicrystal camera. J Nucl Med 1982; 23: 722-30.
6. Conti PS, Keppler JS, Halls JM. Positron emission tomography: a financial and operational analysis. Am J Roentgenol 1994; 162: 1279-86.
7. Drane WE, Abbott FD, Nicole MW et al. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress. Radiology 1994; 191: 461-5.
8. Gambhir SS, Shepherd JE, Shah BD et al. Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 1998; 16: 2113-25.
9. Gupta NC, Frank AR, Dewan NA et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184: 441-4.
10. Hamberg LM, Hunter GJ, Alpert NM et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994; 35: 1308-12.
11. Hoeflin F, Lederman H, Noelpp, UB et al. Routine 18-F-2-dcoxy-fluoro-D-glucose myocardial tomography using a large field of view gamma camera. Angiology 1989; 40: 1058-64.
12. Hoh CK, Glaspy J, Rosen P, Dahlbom M et al. Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997; 38: 343-8.
13. Holle LH, Trampert L, Lung-Kurt S et al. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT. J Nucl Med 1996; 37: 615-22.
14. Jarritt PH, Adams S. PET imaging using gamma camera systems: A rewiev. Nucl Med Commun 1996; 17: 758-66.
15. Lapela M, Grenman R, Kurki T et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205-11.
16. Laubenbacher C, Saumweber D, Wagner-Manslau C et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36: 1747-57.
17. Macfarlane DJ, Cotton L, Ackermann RJ et al. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995; 194: 425-9.
18. Martin WH, Delbeke D, Patton JA et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995; 36: 988-95.
19. Martin WH, Delbeke D, Patton JA et al. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996; 198: 225-31.
20. Muehllehner G. Positron camera with extended counting range capability. J Nucl Med 1975; 16: 653-7.
21. Ogunbiyi OA, Flanagan FL, Dehdashti F et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997; 4: 613-20.
22. Reske SN, Bares R, Büll U et al. Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Nuklearmedizin 1996; 35: 42-52.
23. Rinne D, Baum RP, Hör G et al. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxy-glucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998; 82: 1664-71.
24. Schwaiger M, Ziegler S. PET using a coincidence camera versus ring tomography, progress or recession? Nuklearmedizin 1997; 36: Editorial.
25. Shreve PD, Steventon RS, Deters EC et al. Oncologic diagnosis with 2-[fluorine-18] fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-7.
26. Steinert HC, Hauser M, Allemann F et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative node mapping and sampling. Radiology 1997; 202: 441-6.
27. Thill R, Neuerburg J, Fabry U et al. Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma. Nuklearmedizin 1997; 36: 234-9.
28. Trampert L, Holle LH, Berberich R et al. 18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator. Nuklearmedizin 1995; 34: 79-86.
29. Worsley DF, Celler A, Adam MJ et al. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography. Am J Roentgenol 1997; 168: 771-4.
30. Zasadny KR, Kison PV, Quint LE et al. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans. Radiology 1996; 201: 873-6.
31. Ziegler S, Enterrottacher A, Boening G et al. Untersuchung der Systemeigenschaften einer Doppelkopf-Koinzidenzkamera (abstract). Nuklearmedizin 1998; 37: A64.
32. Zimny M, Schroeder W, Wolters S et al. 18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results. Nuklearmedizin 1997; 36: 228-33.